Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rapid HIV Testing Program in the Emergency Department

This study has been completed.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Temple University
ClinicalTrials.gov Identifier:
NCT00548041
First received: October 19, 2007
Last updated: October 5, 2015
Last verified: October 2015

October 19, 2007
October 5, 2015
April 2007
May 2009   (final data collection date for primary outcome measure)
Feasibility of Rapid HIV Testing in Emergency Department [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Feasibility was assessed as number of participants who were approached and agreed to participate in rapid HIV testing and then had testing completed.
Not Provided
Complete list of historical versions of study NCT00548041 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Rapid HIV Testing Program in the Emergency Department
Pilot Study to Evaluate a Rapid HIV Testing Program in the Emergency Department
The purpose of the study is to evaluate the feasibility of a rapid HIV testing program in the Temple University Hospital(TUH)Emergency Department. We hypothesize that a rapid HIV testing program in the TUH Emergency Department is feasible. Patients presenting to the Adult TUH Emergency Department with certain conditions will be offered rapid HIV testing. Testing will be performed by oral swab using the OraQuick Advance test. Patients will receive post-test counseling.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
HIV Infections
Other: HIV test by oral swab
Eligible subjects underwent rapid HIV testing by oral swab.
Rapid HIV Tested
Subjects have HIV testing by oral swab performed.
Intervention: Other: HIV test by oral swab
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
May 2009
May 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

One of the following conditions:

  • Sexually transmitted disease evaluation or prior history of sexually transmitted disease
  • Pregnancy
  • Clinical condition that suggests possible immunodeficiency
  • History of illicit drug use
  • History of chronic viral hepatitis
  • Patients with unexplained pneumonia or recurrent pneumonia
  • Male patients who have a history of sex with men
  • Abdominal pain in a sexually active woman or urethritis in a man
  • Trauma.
  • Age 18 years old or older.

Exclusion Criteria:

  • Age less than 18 years.
  • None of the above conditions.
Both
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00548041
11007
No
Not Provided
Not Provided
Temple University
Temple University
Gilead Sciences
Principal Investigator: Ellen Tedaldi, M.D. Temple University
Temple University
October 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP